Wealthsource Partners, LLC Gilead Sciences, Inc. Transaction History

Wealthsource Partners, LLC

$1.52 Billion
Q4 2023

A detailed history of Wealthsource Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealthsource Partners, LLC holds 6,872 shares of GILD stock, worth $581,302. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,872

Previous 7,056 2.61%

Holding current value

$581,302

Previous $528,000 5.3%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$73.27 - $83.09 $13,481 - $15,288	-184 Reduced 2.61%	6,872 $556,000
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $3,179 - $3,468	43 Added 0.61%	7,056 $528,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $123,972 - $141,407	-1,631 Reduced 18.87%	7,013 $540,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $9,277 - $10,569	120 Added 1.41%	8,644 $717,000
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $85,191 - $122,305	-1,367 Reduced 13.82%	8,524 $731,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $30,365 - $34,685	510 Added 5.44%	9,891 $610,000
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $18,412 - $20,738	-319 Reduced 3.29%	9,381 $580,000
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $521 - $653	9 Added 0.09%	9,700 $577,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $85,771 - $97,352	1,322 Added 15.8%	9,691 $704,000
Q3 2021 Nov 18, 2021	SELL	$67.69 - $73.03 $63,560 - $68,575	-939 Reduced 10.09%	8,369 $585,000
Q2 2021 Nov 18, 2021	BUY	$63.47 - $69.35 $324,268 - $354,309	5,109 Added 121.67%	9,308 $641,000
Q1 2021 Jun 21, 2021	SELL	$60.0 - $68.46 $144,960 - $165,399	-2,416 Reduced 36.52%	4,199 $271,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $23,679 - $26,981	418 Added 6.75%	6,615 $385,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $42,041 - $52,860	677 Added 12.26%	6,197 $391,000
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $87,025 - $101,052	-1,203 Reduced 17.89%	5,520 $425,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $59,122 - $75,727	-944 Reduced 12.31%	6,723 $503,000
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $376,436 - $414,068	-6,109 Reduced 44.35%	7,667 $498,000
Q3 2019 Nov 15, 2019	SELL	$62.51 - $69.0 $31,442 - $34,707	-503 Reduced 3.52%	13,776 $873,000
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $555,345 - $622,754	8,976 Added 169.26%	14,279 $965,000
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $331,596 - $371,475	5,303 New	5,303 $345,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $207,496 - $229,736	-2,911 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $188,865 - $220,304	2,911 New	2,911 $206,000

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Account

Wealthsource Partners, LLC Gilead Sciences, Inc. Transaction History